Patent · US Active

Compositions comprising CelTOS immunogens and antibodies and method of use thereof

US12398184B2 · kind B2 · utility

0Cited by
18References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 1, 2017
Grant dateAug 26, 2025
Priority date
Expiry dateJun 21, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/445
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides immunogenic compositions and methods for vaccination with a CelTOS immunogen. The immunogenic composition comprises Babesia, Theileria or Cytauxzoon CelTOS. The immunogenic composition may also comprise CelTOS with structural changes that affect immune recognition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.